The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Leukocyte Antigen Typing and Antibody Testing Market Research Report 2025
Synopsis
Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient. HLA genes are highly polymorphic and determine the polymorphism of the expressed HLA antigen molecules. Currently, genotyping detection technology is mainly used for HLA typing. Compared with serological and cytological methods, it has higher sensitivity and accuracy and can detect more types.
The global Human Leukocyte Antigen Typing and Antibody Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Human Leukocyte Antigen Typing and Antibody Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Leukocyte Antigen Typing and Antibody Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Leukocyte Antigen Typing and Antibody Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Leukocyte Antigen Typing and Antibody Testing include Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen Typing and Antibody Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen Typing and Antibody Testing.
The Human Leukocyte Antigen Typing and Antibody Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Leukocyte Antigen Typing and Antibody Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Leukocyte Antigen Typing and Antibody Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Siemens
Roche
Thermo Fisher Scientific
Immucor
CareDx
Natera
Eurofins Scientific
Medix Biochemica
GENDX
CGT Global
Beckman Coulter
Segment by Type
Antigen Typing
Antibody Testing
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Leukocyte Antigen Typing and Antibody Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient. HLA genes are highly polymorphic and determine the polymorphism of the expressed HLA antigen molecules. Currently, genotyping detection technology is mainly used for HLA typing. Compared with serological and cytological methods, it has higher sensitivity and accuracy and can detect more types.
The global Human Leukocyte Antigen Typing and Antibody Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Human Leukocyte Antigen Typing and Antibody Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Leukocyte Antigen Typing and Antibody Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Human Leukocyte Antigen Typing and Antibody Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Human Leukocyte Antigen Typing and Antibody Testing include Abbott, Siemens, Roche, Thermo Fisher Scientific, Immucor, CareDx, Natera, Eurofins Scientific, Medix Biochemica, GENDX, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen Typing and Antibody Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen Typing and Antibody Testing.
The Human Leukocyte Antigen Typing and Antibody Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Leukocyte Antigen Typing and Antibody Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Leukocyte Antigen Typing and Antibody Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Siemens
Roche
Thermo Fisher Scientific
Immucor
CareDx
Natera
Eurofins Scientific
Medix Biochemica
GENDX
CGT Global
Beckman Coulter
Segment by Type
Antigen Typing
Antibody Testing
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Leukocyte Antigen Typing and Antibody Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antigen Typing
1.2.3 Antibody Testing
1.3 Market by Application
1.3.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Perspective (2019-2030)
2.2 Global Human Leukocyte Antigen Typing and Antibody Testing Growth Trends by Region
2.2.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Leukocyte Antigen Typing and Antibody Testing Historic Market Size by Region (2019-2024)
2.2.3 Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Region (2025-2030)
2.3 Human Leukocyte Antigen Typing and Antibody Testing Market Dynamics
2.3.1 Human Leukocyte Antigen Typing and Antibody Testing Industry Trends
2.3.2 Human Leukocyte Antigen Typing and Antibody Testing Market Drivers
2.3.3 Human Leukocyte Antigen Typing and Antibody Testing Market Challenges
2.3.4 Human Leukocyte Antigen Typing and Antibody Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Leukocyte Antigen Typing and Antibody Testing Players by Revenue
3.1.1 Global Top Human Leukocyte Antigen Typing and Antibody Testing Players by Revenue (2019-2024)
3.1.2 Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Players (2019-2024)
3.2 Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Leukocyte Antigen Typing and Antibody Testing Revenue
3.4 Global Human Leukocyte Antigen Typing and Antibody Testing Market Concentration Ratio
3.4.1 Global Human Leukocyte Antigen Typing and Antibody Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Leukocyte Antigen Typing and Antibody Testing Revenue in 2023
3.5 Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing Head office and Area Served
3.6 Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Product and Application
3.7 Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Leukocyte Antigen Typing and Antibody Testing Breakdown Data by Type
4.1 Global Human Leukocyte Antigen Typing and Antibody Testing Historic Market Size by Type (2019-2024)
4.2 Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Type (2025-2030)
5 Human Leukocyte Antigen Typing and Antibody Testing Breakdown Data by Application
5.1 Global Human Leukocyte Antigen Typing and Antibody Testing Historic Market Size by Application (2019-2024)
5.2 Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size (2019-2030)
6.2 North America Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024)
6.4 North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size (2019-2030)
7.2 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024)
7.4 Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size (2019-2030)
8.2 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size (2019-2030)
9.2 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024)
9.4 Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size (2019-2030)
10.2 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.1.4 Abbott Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Siemens
11.2.1 Siemens Company Details
11.2.2 Siemens Business Overview
11.2.3 Siemens Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.2.4 Siemens Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.2.5 Siemens Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.3.4 Roche Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Immucor
11.5.1 Immucor Company Details
11.5.2 Immucor Business Overview
11.5.3 Immucor Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.5.4 Immucor Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.5.5 Immucor Recent Development
11.6 CareDx
11.6.1 CareDx Company Details
11.6.2 CareDx Business Overview
11.6.3 CareDx Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.6.4 CareDx Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.6.5 CareDx Recent Development
11.7 Natera
11.7.1 Natera Company Details
11.7.2 Natera Business Overview
11.7.3 Natera Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.7.4 Natera Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.7.5 Natera Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.8.4 Eurofins Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Medix Biochemica
11.9.1 Medix Biochemica Company Details
11.9.2 Medix Biochemica Business Overview
11.9.3 Medix Biochemica Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.9.4 Medix Biochemica Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.9.5 Medix Biochemica Recent Development
11.10 GENDX
11.10.1 GENDX Company Details
11.10.2 GENDX Business Overview
11.10.3 GENDX Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.10.4 GENDX Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.10.5 GENDX Recent Development
11.11 CGT Global
11.11.1 CGT Global Company Details
11.11.2 CGT Global Business Overview
11.11.3 CGT Global Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.11.4 CGT Global Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.11.5 CGT Global Recent Development
11.12 Beckman Coulter
11.12.1 Beckman Coulter Company Details
11.12.2 Beckman Coulter Business Overview
11.12.3 Beckman Coulter Human Leukocyte Antigen Typing and Antibody Testing Introduction
11.12.4 Beckman Coulter Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
11.12.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antigen Typing
Table 3. Key Players of Antibody Testing
Table 4. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region (2019-2024)
Table 8. Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region (2025-2030)
Table 10. Human Leukocyte Antigen Typing and Antibody Testing Market Trends
Table 11. Human Leukocyte Antigen Typing and Antibody Testing Market Drivers
Table 12. Human Leukocyte Antigen Typing and Antibody Testing Market Challenges
Table 13. Human Leukocyte Antigen Typing and Antibody Testing Market Restraints
Table 14. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Players (2019-2024)
Table 16. Global Top Human Leukocyte Antigen Typing and Antibody Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen Typing and Antibody Testing as of 2023)
Table 17. Ranking of Global Top Human Leukocyte Antigen Typing and Antibody Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Human Leukocyte Antigen Typing and Antibody Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Headquarters and Area Served
Table 20. Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Product and Application
Table 21. Global Key Players of Human Leukocyte Antigen Typing and Antibody Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Human Leukocyte Antigen Typing and Antibody Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Human Leukocyte Antigen Typing and Antibody Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Company Details
Table 47. Abbott Business Overview
Table 48. Abbott Human Leukocyte Antigen Typing and Antibody Testing Product
Table 49. Abbott Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. Siemens Company Details
Table 52. Siemens Business Overview
Table 53. Siemens Human Leukocyte Antigen Typing and Antibody Testing Product
Table 54. Siemens Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 55. Siemens Recent Development
Table 56. Roche Company Details
Table 57. Roche Business Overview
Table 58. Roche Human Leukocyte Antigen Typing and Antibody Testing Product
Table 59. Roche Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Thermo Fisher Scientific Company Details
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Human Leukocyte Antigen Typing and Antibody Testing Product
Table 64. Thermo Fisher Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Immucor Company Details
Table 67. Immucor Business Overview
Table 68. Immucor Human Leukocyte Antigen Typing and Antibody Testing Product
Table 69. Immucor Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 70. Immucor Recent Development
Table 71. CareDx Company Details
Table 72. CareDx Business Overview
Table 73. CareDx Human Leukocyte Antigen Typing and Antibody Testing Product
Table 74. CareDx Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 75. CareDx Recent Development
Table 76. Natera Company Details
Table 77. Natera Business Overview
Table 78. Natera Human Leukocyte Antigen Typing and Antibody Testing Product
Table 79. Natera Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 80. Natera Recent Development
Table 81. Eurofins Scientific Company Details
Table 82. Eurofins Scientific Business Overview
Table 83. Eurofins Scientific Human Leukocyte Antigen Typing and Antibody Testing Product
Table 84. Eurofins Scientific Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 85. Eurofins Scientific Recent Development
Table 86. Medix Biochemica Company Details
Table 87. Medix Biochemica Business Overview
Table 88. Medix Biochemica Human Leukocyte Antigen Typing and Antibody Testing Product
Table 89. Medix Biochemica Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 90. Medix Biochemica Recent Development
Table 91. GENDX Company Details
Table 92. GENDX Business Overview
Table 93. GENDX Human Leukocyte Antigen Typing and Antibody Testing Product
Table 94. GENDX Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 95. GENDX Recent Development
Table 96. CGT Global Company Details
Table 97. CGT Global Business Overview
Table 98. CGT Global Human Leukocyte Antigen Typing and Antibody Testing Product
Table 99. CGT Global Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 100. CGT Global Recent Development
Table 101. Beckman Coulter Company Details
Table 102. Beckman Coulter Business Overview
Table 103. Beckman Coulter Human Leukocyte Antigen Typing and Antibody Testing Product
Table 104. Beckman Coulter Revenue in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024) & (US$ Million)
Table 105. Beckman Coulter Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Human Leukocyte Antigen Typing and Antibody Testing Picture
Figure 2. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Type: 2023 VS 2030
Figure 4. Antigen Typing Features
Figure 5. Antibody Testing Features
Figure 6. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Human Leukocyte Antigen Typing and Antibody Testing Report Years Considered
Figure 12. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Human Leukocyte Antigen Typing and Antibody Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Human Leukocyte Antigen Typing and Antibody Testing Market Share by Players in 2023
Figure 16. Global Top Human Leukocyte Antigen Typing and Antibody Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Leukocyte Antigen Typing and Antibody Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Human Leukocyte Antigen Typing and Antibody Testing Revenue in 2023
Figure 18. North America Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2019-2030)
Figure 20. United States Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2019-2030)
Figure 24. Germany Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Human Leukocyte Antigen Typing and Antibody Testing Market Share by Region (2019-2030)
Figure 32. China Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2019-2030)
Figure 40. Mexico Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Human Leukocyte Antigen Typing and Antibody Testing Market Share by Country (2019-2030)
Figure 44. Turkey Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Human Leukocyte Antigen Typing and Antibody Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Abbott Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 48. Siemens Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 51. Immucor Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 52. CareDx Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 53. Natera Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 54. Eurofins Scientific Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 55. Medix Biochemica Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 56. GENDX Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 57. CGT Global Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 58. Beckman Coulter Revenue Growth Rate in Human Leukocyte Antigen Typing and Antibody Testing Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
